Virbac operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other
companies in this sector in France:
sales of 617.54 million Euro [US$758.65 million]
of which 50%
was Non-Proprietary Homeopathic Medicines),
(812.40 million Euro [US$998.03 million]
(352.20 million Euro [US$432.68 million]
Virbac reported sales of 861.88 million Euro (US$1.06 billion)
December of 2017.
decrease of 1.1%
versus 2016, when the company's sales were 871.83 million Euro.